Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7504 p670
31 May 2008


Society summary


Funding members’ needs is paramount to success

Andrew Gush

The Treasurer: the Society needs members’ support, advice and input

Funding pharmacists’ needs is paramount to the success of pharmacy’s new professional body, the Treasurer of the Royal Pharmaceutical Society, Andrew Gush, told the Society’s annual general meeting on 21 May 2008. The Society needed members’ support, advice, recommendations and input to make it a success.

Presenting the 2007 financial statements to the AGM, he said that his year as Treasurer had been challenging and had involved managing unpopular decisions. However, he was honoured to work on behalf of the membership to ensure the Society’s finances were in order.

An early task had been to set some strategic objectives for 2007 and 2008. These were:

  • to ensure the Society’s reserves were built to a level that would meet future liabilities
  • to communicate with members on the Society’s finances
  • to review the 2008 budget rigorously, with target savings to be achieved
  • to ensure the Society spent funds to the benefit of the membership
  • to consult on membership fee categories, focusing on staged payments and low income fees

On his first day as Treasurer he had inherited a proposal for a large increase in membership fees. The Society’s reserves were too low to deal with the escalating cost of regulation and pension fund problems (as experienced by many organisations).

The members had not welcomed the Council’s fees decision, but a smaller increase would have been irresponsible and dishonest. The way forward had to be based on stable finances, underpinned by timely and proportionate financial control.

The Treasurer added that since June 2007 he had communicated with members to try to illustrate the work required in balancing the books in a changing environment made more complex with the move towards demerger.

The AGM was also an opportunity to advise members of the Society’s approach to its 2008 budget. Measures to ensure the budget met membership needs included making funds available for increased media attention, increased communication, a high profile for the profession and increased information and guidance for pharmacists.

In addition, the team had looked at alternative funding sources to assist with the Society’s long-term financial commitments (eg, alternative charities to provide research grants). Significant savings had been made.

Finally, the Society had worked with the Department of Health to secure funding to support the transitional costs in creating the new regulator. So far, it had secured an extra £2m. It was committed to productive dialogue with its members, which would continue as financial support was required in setting up the new professional body.

Paying the annual fee was a big issue, and he had worked with the Council and staff to introduce staged payments and low income fees. Staged payments were now following the parliamentary process and were expected to be in place this summer. Recommendations for low income fees would form part of the 2009 consultation. He hoped that many members would contribute to the consultation.

The 2009 retention fee would form part of this consultation. A number of options would be presented to members to enable the support of staged papers and low income fees.

Turning to the 2007 financial results, the Treasurer said that the deficit on ordinary activities before tax of £220,000 was in line with the budget forecast presented during the second half of 2007. Significant work had been undertaken to minimise tax liability, and the Society had achieved a result of £260,000 against a forecasted liability of £800,000.

The strategic objectives for 2008 were:

• To produce a secure financial framework for the new professional body that is sustainable, can deliver relevant quality services and is affordable to potential members

• For expenditure to be further directed to the benefit of the members

• To continue working with the DoH to secure additional funding where necessary

• For the British Pharmaceutical Conference to become an income-generating event

• To look at creative ways of solving the pension fund deficit

• To support members with new fee types

• To produce and manage budgets for the President, Council and committees

Bernard Kelly, director of finance and resources, said that the Society had continued to pursue the financial strategy reported to the 2007 AGM. However, the benefits of the strategy were not yet reflected in the financial statements. One outcome of the strategy had been the increase in fees in 2008. This had been a tough but necessary decision.

The 2007 deficit of £220,000 before tax compared to a 2006 surplus of £112,000 after Gift Aid payments of £853,000. The Society’s finances were being squeezed between increased costs arising from the Section 60 Order implementation and the limited increase in retention fees in the previous two years.

For 2007, the Society could make no Gift Aid payments because of changes in legislation. Eventually it had had to pay corporation tax of £260,000. Taking tax and Gift Aid into account, the Society had faced a substantial turn-around in its finances, which helped underline the need for the fee increases in 2008.

A good way to check an organisation’s health was to look at its balance sheet. In the Society’s case, this showed a relatively stable position, with the exception of the pension fund figures, which had been volatile.

Two significant figures were the cash balance of £12.9m at the year end and creditors of £18.5m. These figures were significantly higher than for 2006 and reflected the large number of members using the internet to pay their 2008 fees before 31 December 2007.

Pensions liability had gone from a deficit of £4.4m to a surplus of £0.7m within 12 months. As a result, the reserves and assets appeared to have more than doubled in the year.

After offering a short masterclass in pension fund accounting to explain how the pensions liability was calculated, Mr Kelly said that, because of the impact of the deficit on the cost of maintaining the pension fund, the Society had been consulting with staff who are members of the scheme about limiting future pension benefits to be accrued. If implemented, the changes would reduce the cost of maintaining the scheme.

Before ending his presentation, Mr Kelly said that he wished to clarify an issue with regard to the presentation of Council members’ expenses in the annual review and in particular the President’s expenses. The figures had been distorted by a change in their presentation and also by the fact that discussion in 2006 on the issue of attendance fees and allowances had failed to reach a conclusion and the 2006 allowances for the President and Vice-President had not been paid until 2007. The President’s expenses had also risen because of a significant additional level of activity arising from the White Paper and the prospective demerger of the Society.

In reply to a question, Mr Kelly said that the Society’s Gift Aid had been made to the Charities Aid Foundation and subsequently paid into the Pharmaceutical Trust for Education and Charitable Objectives, a subsidiary of the Society. It was a tax-efficient way to support the Pharmacy Practice Research Trust and other areas of cost previously funded directly by the Society. Most of the money still existed and was still available to fund activities such as research and education.

In response to a question about a discrepancy in the annual review, it was reported that the number of international registrations in 2007 should have been given as 117, not 1,171.

Back to Top


©The Pharmaceutical Journal